Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Immune system failure in hair follicles causes lichen planopilaris, leading to hair loss.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Sparse hairless patches can develop and stabilize in alopecia areata under certain conditions.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Hair cortisol levels peak in the third trimester and decline postpartum.

Fetal skin has unique immune cells different from adult skin.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

MC-1R in skin cells may influence inflammation and collagen production.

Cholesterol issues in skin and hair may cause permanent hair loss by triggering inflammation.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Vitiligo is a systemic disease with psychological effects, and new treatments focus on personalized care.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

Recent advancements in hair loss treatments include new therapies and insights for different types of alopecia.

BTNL2 helps protect hair follicles from immune attacks.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Restoring hair follicle immune privilege may help treat alopecia areata.

Reducing CD8+ T cell growth can stabilize alopecia areata.